Sort   by:  
 Page size 
UnknownEvaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosis.
Not available
S-EPMC12417267 | biostudies-literature
UnknownAnti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
Not available
S-EPMC13473194 | biostudies-literature
UnknownHighly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
Not available
S-EPMC10862269 | biostudies-literature
UnknownHigh-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
Not available
S-EPMC10964164 | biostudies-literature
UnknownConstitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
Not available
S-EPMC5445615 | biostudies-literature
UnknownAssessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Not available
S-EPMC5568360 | biostudies-literature
UnknownTarget trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
Not available
S-EPMC12911643 | biostudies-literature
Sort   by:  
 Page size